On Invalid Date, Neurobo Pharmaceuticals (NASDAQ: NRBO) reported Q4 2023 earnings per share (EPS) of -$1.02, up 102.54% year over year. Total Neurobo Pharmaceuticals earnings for the quarter were -$5.31 million. In the same quarter last year, Neurobo Pharmaceuticals's earnings per share (EPS) was $40.18.
As of Q1 2024, Neurobo Pharmaceuticals's earnings has grown year over year. Neurobo Pharmaceuticals's earnings in the past year totalled -$12.47 million.
What is NRBO's earnings date?
Neurobo Pharmaceuticals's earnings date is Invalid Date. Add NRBO to your watchlist to be reminded of NRBO's next earnings announcement.
What was NRBO's revenue last quarter?
On Invalid Date, Neurobo Pharmaceuticals (NASDAQ: NRBO) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Neurobo Pharmaceuticals's revenue was $0.00.
What was NRBO's revenue growth in the past year?
As of Q1 2024, Neurobo Pharmaceuticals's revenue has grown null year over year. Neurobo Pharmaceuticals's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.